CBCA Diversity Disclosure Requirements Effective for 2020 Proxy Season
For the upcoming 2020 proxy season, new disclosure requirements will be effective for publicly-listed corporations incorporated under the Canada Business Corporations Act (CBCA). They mandate additional diversity disclosure in connection with an annual meeting of shareholders held on or after January 1, 2020. Notably, the new regulations align with the “comply or explain” regime adopted under Canadian securities laws, which prescribe disclosure regarding gender diversity on boards and in senior management. But the regulations also go beyond these requirements by (i) expanding the scope to include diversity disclosure with respect to a broader range of “designated groups”1, and (ii) requiring such disclosure from “venture” issuers in addition to “non-venture” issuers (i.e., issuers listed on the Toronto Stock Exchange (TSX), TSX Venture Exchange (TSX-V) and Canadian Securities Exchange (CSE)).
The CBCA amendments implement parts of Bill C-25, An Act to amend the Canada Business Corporations Act, the Canada Cooperatives Act, the Canada Not-for-profit Corporations Act and the Competition Act, which received assent on May 1, 2018 (available here), and the corresponding Regulations Amending the Canada Business Corporations Regulations, 2001: SOR/2019-258 (available here).
Details of Required Disclosure
Commencing with their 2020 annual shareholder meetings, publicly-listed CBCA corporations will need to disclose in their management information circulars the following information:
1. Term Limits. Whether the corporation has adopted term limits or other mechanisms of board renewal and either a description of those term limits or mechanisms or the reasons why it has not adopted them.
2. Written Policies. Whether the corporation has a written policy relating to the identification and nomination of directors from the designated groups and, where it does not have a policy, the reasons for not adopting one or, where it has a policy, the following information:
i. a short summary of the policy’s objectives and key provisions;
ii. a description of the measures taken to ensure effective implementation;
iii. a description of the annual and cumulative progress in achieving the objectives of the policy; and
iv. whether the effectiveness of the policy is measured and, if so, a description of how it is measured.
3. Level of Representation. Whether the level of representation of the designated groups is considered when nominating individuals as directors and when appointing members of senior management2 and a description of how that level is considered or, if not considered, the reasons why not.
4. Targets. Whether there are targets for representation on the board and among senior management for each of the designated groups and, if so, a description of the progress made in achieving the targets and, for each group with a target, the annual and cumulative progress in achieving that target or, if there is no target, the reasons for not adopting a target.
5. Statistics. The number and proportion (in percentage terms) of members from each of the designated groups on the board and in senior management.
Other CBCA Amendments
Other amendments to the CBCA related to annual shareholder meetings have been passed, but are not yet in force. Such amendments include reforms with respect to majority voting requirements, say-on-pay, clawback policies, disclosure related to well-being, director elections, shareholder proposals and notice-and-access. We will provide an additional update and guidance when these amendments come into force.
1 For the purposes of the requirements, “designated groups” is defined with reference to the federal Employment Equity Act, and includes women, Aboriginal peoples, persons with disabilities and members of visible minorities. Corporations may rely on self-identification by members of the designated groups (e.g., by including voluntary questions in the annual questionnaire) for disclosure purposes.
2 For the purposes of the requirements, “senior management” is defined to include the chair and vice-chair of the board of directors, president, chief executive officer, chief financial officer, vice-presidents in charge of a principal business unit, division or function, and individuals performing a policymaking function in respect of the corporation.
Expertise
Authors
Insights
-
REITS and Income Securities
The Legal Industry Reviews Edition 7 - REITs Chapter
Stephen Pincus, Brenda Gosselin, and Bill Gorman have co-authored The Canadian REIT Structure in the seventh edition of The Legal Industry Reviews Canada.To view the… -
Capital Markets
Proxy Advisors Update Canadian Voting Guidelines for 2025
In late 2024, Institutional Shareholder Services (ISS) and Glass Lewis, two leading North American proxy advisory firms, updated their benchmark proxy voting guidelines ahead of the 2025 proxy season… -
Capital Markets
Going Public in Canada
Going Public in Canada was developed by Goodmans LLP to provide a practical overview of the initial public offering (“IPO”) process. The information in this guide is limited to the laws and guidance… -
Capital Markets
Canada Initiates Consultations and Proposes New Measures to Strengthen Anti-Modern Slavery Efforts
The Fighting Against Forced Labour and Child Labour in Supply Chains Act (the “Act”) came into force on January 1, 2024, implementing enhanced reporting requirements for certain entities to combat… -
Capital Markets
New Guidance for Evaluating Poison Pills in Ontario
Eight years after the Canadian Securities Administrators (CSA) adopted fundamental amendments to Canada’s take-over bid regime in May 2016, regulators and other market participants continue to grapple… -
Capital Markets
Canadian Securities Regulators Moving Forward With Access Model for Delivery of Continuous Disclosure Documents
On November 19, 2024, the Canadian Securities Administrators (CSA) announced they are moving forward with the previously announced access model (the “Access Model”) for non-investment fund reporting…
Featured Work
-
Capital Markets
Northwest Healthcare Properties Real Estate Investment Trust announces inaugural unsecured debentures offering
Goodmans LLP advised Northwest Healthcare Properties REIT in connection with a private placement offering of $500 million aggregate principal amount of senior unsecured debentures of the REIT in two… -
Capital Markets
Raymond James Ltd. facilitates $30 million equity financing for Medexus Pharmaceuticals Inc.
Goodmans LLP acted for Raymond James Ltd., as lead underwriter and sole bookrunner, in connection with the $30 million equity financing of Medexus Pharmaceuticals Inc. by way of shelf prospectus… -
Capital Markets
Mandalay Resources Corporation Base Shelf Prospectus
Goodmans LLP advised Mandalay Resources Corporation in connection with its base shelf prospectus dated December… -
Mergers and Acquisitions
NexPoint Hospitality Trust to be acquired by NexPoint Diversified Real Estate Trust
Goodmans LLP is advising NexPoint Hospitality Trust in connection with its announced acquisition by NexPoint Diversified Real Estate Trust… -
Capital Markets
Cormark Securities Inc. leads $51.75 million bought deal offering for Kraken Robotics
Goodmans LLP acted for the underwriters in connection with a bought deal short form prospectus offering of over 32.3 million common shares of Kraken Robotics Inc. for gross proceeds of C$51.75 million… -
SPACS
FG Acquisition Corp. completes acquisition of Strong/MDI Screen Systems Inc. and launches Saltire Capital Ltd.
Goodmans LLP acted for FG Acquisition Corp. ("FGAC"), a special purpose acquisition company, in connection with its acquisition of Strong/MDI Screen Systems, Inc., a leading manufacturer and…
News & Events
-
Banking and Financial Services
Chambers and Partners Once Again Honours Goodmans with Global Recognition
We are proud to announce Goodmans LLP continues to receive top-tier recognition from Chambers and Partners in the Chambers Global 2025 Guide released today.Recognition from Chambers and Partners is… -
Banking and Financial Services
Goodmans Featured in the 2025 Lexpert's Leading 500 Cross-Border Lawyers: A Guide to Doing Business in Canada
We are pleased to announce that Lexpert's Leading 500 Cross-Border Lawyers: A Guide to Doing Business in Canada once again recognizes Goodmans in their 2025 Guide.The Lexpert 500, produced in… -
Banking and Financial Services
IFLR1000 2024 Recognizes Goodmans Lawyers and Practices
We are proud to announce Goodmans continues to be recognized by IFLR1000 in its annual guide.Recognition in IFLR1000 is based on a combination of in-depth qualitative research and direct client…